Curis
CRIS
#10201
Rank
S$22.61 M
Marketcap
S$1.75
Share price
0.00%
Change (1 day)
-66.91%
Change (1 year)

Curis (CRIS) - Total assets

Total assets on the balance sheet as of September 2025 : S$35.81 Million

According to Curis's latest financial reports the company's total assets are S$35.81 Million. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Curis - Total assets on balance sheet (from 2001 to 2025)

Total assets by year

Year Total assets Change
2024-12-31S$56.09 M-45.05%
2023-12-31S$0.10 B-30.05%
2022-12-31S$0.14 B-33.5%
2021-12-31S$0.21 B-18.84%
2020-12-31S$0.27 B471.2%
2019-12-31S$47.33 M-7.28%
2018-12-31S$51.04 M-48.28%
2017-12-31S$98.7 M18.09%
2016-12-31S$83.58 M-37.78%
2015-12-31S$0.13 B62.37%
2014-12-31S$82.73 M-18.97%
2013-12-31S$0.10 B19.68%
2012-12-31S$85.31 M36.74%
2011-12-31S$62.39 M-4.36%
2010-12-31S$65.24 M28.73%
2009-12-31S$50.67 M-11.37%
2008-12-31S$57.17 M-26.17%
2007-12-31S$77.44 M-3.38%
2006-12-31S$80.14 M-20.98%
2005-12-31S$0.10 B-7.67%
2004-12-31S$0.10 B16%
2003-12-31S$94.69 M-12.6%
2002-12-31S$0.10 B-59.57%
2001-12-31S$0.26 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Exelixis
EXEL
S$3.65 B 10,115.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
S$1.89 B 5,185.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
S$0.13 B 289.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
S$0.84 B 2,245.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$270.49 B 755,049.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$125.55 B 350,426.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
S$26.35 M-26.43%๐Ÿ‡บ๐Ÿ‡ธ USA